Hysterectomy and concurrent oophorectomy for endometrial cancer: which women benefit?

References

• Jemal A, Siegel R, Ward E et al. Cancer statistics, 2008. CA Cancer J. Clin.58(2), 71–96 (2008).
   PubMed Web of Science ®Google Scholar
• Lee NK, Cheung MK, Shin JY et al. Prognostic factors for uterine cancer in reproductive-aged women. Obstet. Gynecol.109(3), 655–662 (2007).
   PubMed Web of Science ®Google Scholar
• Gitsch G, Hanzal E, Jensen D, Hacker NF. Endometrial cancer in premenopausal women 45 years and younger. Obstet. Gynecol.85(4), 504–508 (1995).
   PubMed Web of Science ®Google Scholar
• Duska LR, Garrett A, Rueda BR, Haas J, Chang Y, Fuller AF. Endometrial cancer in women 40 years old or younger. Gynecol. Oncol.83(2), 388–393 (2001).
   PubMed Web of Science ®Google Scholar
• Crissman JD, Azoury RS, Barnes AE, Schellhas HF. Endometrial carcinoma in women 40 years of age or younger. Obstet. Gynecol.57(6), 699–704 (1981).
   PubMed Web of Science ®Google Scholar
• Evans-Metcalf ER, Brooks SE, Reale FR, Baker SP. Profile of women 45 years of age and younger with endometrial cancer. Obstet. Gynecol.91(3), 349–354 (1998).
   PubMed Web of Science ®Google Scholar
• Gallup DG, Stock RJ. Adenocarcinoma of the endometrium in women 40 years of age or younger. Obstet. Gynecol.64(3), 417–420 (1984).
   PubMed Web of Science ®Google Scholar
• Tran BN, Connell PP, Waggoner S, Rotmensch J, Mundt AJ. Characteristics and outcome of endometrial carcinoma patients age 45 years and younger. Am. J. Clin. Oncol.23(5), 476–480 (2000).
   PubMed Web of Science ®Google Scholar
• Ramirez PT, Frumovitz M, Bodurka DC, Sun CC, Levenback C. Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review. Gynecol. Oncol.95(1), 133–138 (2004).
   PubMed Web of Science ®Google Scholar
• Parker WH, Broder MS, Chang E et al. Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses’ health study. Obstet. Gynecol.113(5), 1027–1037 (2009).
   PubMed Web of Science ®Google Scholar
• Parker WH, Broder MS, Liu Z, Shoupe D, Farquhar C, Berek JS. Ovarian conservation at the time of hysterectomy for benign disease. Obstet. Gynecol.106(2), 219–226 (2005).
   PubMed Web of Science ®Google Scholar
• Rocca WA, Grossardt BR, de Andrade M, Malkasian GD, Melton LJ 3rd. Survival patterns after oophorectomy in premenopausal women: a population-based cohort study. Lancet Oncol.7(10), 821–828 (2006).
   PubMed Web of Science ®Google Scholar
• Klein NA, Battaglia DE, Miller PB, Branigan EF, Giudice LC, Soules MR. Ovarian follicular development and the follicular fluid hormones and growth factors in normal women of advanced reproductive age. J. Clin. Endocrinol. Metab.81(5), 1946–1951 (1996).
   PubMed Web of Science ®Google Scholar
• Ushiroyama T, Sugimoto O. Endocrine function of the peri- and postmenopausal ovary. Horm. Res.44(2), 64–68 (1995).
   PubMedGoogle Scholar
• Longcope C. Endocrine function of the postmenopausal ovary. J. Soc. Gynecol. Investig.8(1 Suppl. Proceedings), S67–S68 (2001).
   Google Scholar
• Fogle RH, Stanczyk FZ, Zhang X, Paulson RJ. Ovarian androgen production in postmenopausal women. J. Clin. Endocrinol. Metab.92(8), 3040–3043 (2007).
   PubMed Web of Science ®Google Scholar
• Partridge E, Kreimer AR, Greenlee RT et al. Results from four rounds of ovarian cancer screening in a randomized trial. Obstet. Gynecol.113(4), 775–782 (2009).
   PubMed Web of Science ®Google Scholar
• Menon U, Gentry-Maharaj A, Hallett R et al. Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Lancet Oncol.10(4), 327–340 (2009).
   PubMed Web of Science ®Google Scholar
• Lindor NM, Petersen GM, Hadley DW et al. Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA296(12), 1507–1517 (2006).
   PubMed Web of Science ®Google Scholar
• Schmeler KM, Lu KH. Gynecologic cancers associated with Lynch syndrome/HNPCC. Clin. Transl. Oncol.10(6), 313–317 (2008).
   PubMed Web of Science ®Google Scholar
• Lu KH, Schorge JO, Rodabaugh KJ et al. Prospective determination of prevalence of lynch syndrome in young women with endometrial cancer. J. Clin. Oncol.25(33), 5158–5164 (2007).
   PubMed Web of Science ®Google Scholar
• Parazzini F, Negri E, La Vecchia C, Luchini L, Mezzopane R. Hysterectomy, oophorectomy, and subsequent ovarian cancer risk. Obstet. Gynecol.81(3), 363–366 (1993).
   PubMed Web of Science ®Google Scholar
• Hankinson SE, Hunter DJ, Colditz GA et al. Tubal ligation, hysterectomy, and risk of ovarian cancer. A prospective study. JAMA270(23), 2813–2818 (1993).
   PubMed Web of Science ®Google Scholar
• Shoupe D, Parker WH, Broder MS, Liu Z, Farquhar C, Berek JS. Elective oophorectomy for benign gynecological disorders. Menopause14(3 Pt 2), 580–585 (2007).
   PubMed Web of Science ®Google Scholar
• Kontoravdis A, Kalogirou D, Antoniou G, Kontoravdis N, Karakitsos P, Zourlas PA. Prophylactic oophorectomy in ovarian cancer prevention. Int. J. Gynaecol. Obstet.54(3), 257–262 (1996).
   PubMed Web of Science ®Google Scholar
• Nguyen HN, Averette HE, Janicek M. Ovarian carcinoma. A review of the significance of familial risk factors and the role of prophylactic oophorectomy in cancer prevention. Cancer74(2), 545–555 (1994).
   PubMed Web of Science ®Google Scholar
• Olson JE, Sellers TA, Iturria SJ, Hartmann LC. Bilateral oophorectomy and breast cancer risk reduction among women with a family history. Cancer Detect. Prev.28(5), 357–360 (2004).
   PubMedGoogle Scholar
• Eisen A, Lubinski J, Klijn J et al. Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case–control study. J. Clin. Oncol.23(30), 7491–7496 (2005).
   PubMed Web of Science ®Google Scholar
• Schairer C, Persson I, Falkeborn M, Naessen T, Troisi R, Brinton LA. Breast cancer risk associated with gynecologic surgery and indications for such surgery. Int. J. Cancer70(2), 150–154 (1997).
   PubMed Web of Science ®Google Scholar
• Kreiger N, Sloan M, Cotterchio M, Kirsh V. The risk of breast cancer following reproductive surgery. Eur. J. Cancer35(1), 97–101 (1999).
   PubMed Web of Science ®Google Scholar
• Kauff ND, Domchek SM, Friebel TM et al. Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study. J. Clin. Oncol.26(8), 1331–1337 (2008).
   PubMed Web of Science ®Google Scholar
• Dekel A, Efrat Z, Orvieto R et al. The residual ovary syndrome: a 20-year experience. Eur. J. Obstet. Gynecol. Reprod. Biol.68(1–2), 159–164 (1996).
   PubMed Web of Science ®Google Scholar
• Atsma F, Bartelink ML, Grobbee DE, van der Schouw YT. Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis. Menopause13(2), 265–279 (2006).
   PubMed Web of Science ®Google Scholar
• Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH. Menopause and the risk of coronary heart disease in women. N. Engl. J. Med.316(18), 1105–1110 (1987).
   PubMed Web of Science ®Google Scholar
• Cooper GS, Sandler DP. Age at natural menopause and mortality. Ann. Epidemiol.8(4), 229–235 (1998).
   PubMed Web of Science ®Google Scholar
• Gordon T, Kannel WB, Hjortland MC, McNamara PM. Menopause and coronary heart disease. The Framingham Study. Ann. Intern. Med.89(2), 157–161 (1978).
   PubMed Web of Science ®Google Scholar
• Jacobsen BK, Nilssen S, Heuch I, Kvale G. Does age at natural menopause affect mortality from ischemic heart disease? J. Clin. Epidemiol.50(4), 475–479 (1997).
   PubMed Web of Science ®Google Scholar
• Rosenberg L, Hennekens CH, Rosner B, Belanger C, Rothman KJ, Speizer FE. Early menopause and the risk of myocardial infarction. Am. J. Obstet. Gynecol.139(1), 47–51 (1981).
   PubMed Web of Science ®Google Scholar
• Lobo RA. Surgical menopause and cardiovascular risks. Menopause14(3 Pt 2), 562–566 (2007).
   PubMed Web of Science ®Google Scholar
• Howard BV, Kuller L, Langer R et al. Risk of cardiovascular disease by hysterectomy status, with and without oophorectomy: the Women’s Health Initiative Observational Study. Circulation111(12), 1462–1470 (2005).
   PubMed Web of Science ®Google Scholar
• Lokkegaard E, Jovanovic Z, Heitmann BL, Keiding N, Ottesen B, Pedersen AT. The association between early menopause and risk of ischaemic heart disease: influence of Hormone Therapy. Maturitas53(2), 226–233 (2006).
   PubMed Web of Science ®Google Scholar
• Parrish HM, Carr CA, Hall DG, King TM. Time interval from castration in premenopausal women to development of excessive coronary atherosclerosis. Am. J. Obstet. Gynecol.99(2), 155–162 (1967).
   PubMed Web of Science ®Google Scholar
• Mosca L, Collins P, Herrington DM et al. Hormone replacement therapy and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation104(4), 499–503 (2001).
   PubMed Web of Science ®Google Scholar
• Aitken JM, Hart DM, Anderson JB, Lindsay R, Smith DA, Speirs CF. Osteoporosis after oophorectomy for non-malignant disease in premenopausal women. Br. Med. J.2(5862), 325–328 (1973).
   PubMedGoogle Scholar
• Gallagher JC. Effect of early menopause on bone mineral density and fractures. Menopause14(3 Pt 2), 567–571 (2007).
   PubMed Web of Science ®Google Scholar
• van Der Voort DJ, van Der Weijer PH, Barentsen R. Early menopause: increased fracture risk at older age. Osteoporos. Int.14(6), 525–530 (2003).
   PubMed Web of Science ®Google Scholar
• Melton LJ 3rd, Khosla S, Malkasian GD, Achenbach SJ, Oberg AL, Riggs BL. Fracture risk after bilateral oophorectomy in elderly women. J. Bone Miner. Res.18(5), 900–905 (2003).
   PubMed Web of Science ®Google Scholar
• Rocca WA, Bower JH, Maraganore DM et al. Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology69(11), 1074–1083 (2007).
   PubMed Web of Science ®Google Scholar
• Rocca WA, Grossardt BR, Maraganore DM. The long-term effects of oophorectomy on cognitive and motor aging are age dependent. Neurodegener. Dis.5(3–4), 257–260 (2008).
   PubMed Web of Science ®Google Scholar
• Sherwin BB. The clinical relevance of the relationship between estrogen and cognition in women. J. Steroid Biochem. Mol. Biol.106(1–5), 151–156 (2007).
   PubMed Web of Science ®Google Scholar
• Yaffe K, Sawaya G, Lieberburg I, Grady D. Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA279(9), 688–695 (1998).
   PubMed Web of Science ®Google Scholar
• LeBlanc ES, Janowsky J, Chan BK, Nelson HD. Hormone replacement therapy and cognition: systematic review and meta-analysis. JAMA285(11), 1489–1499 (2001).
   PubMed Web of Science ®Google Scholar
• Hogervorst E, Williams J, Budge M, Riedel W, Jolles J. The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis. Neuroscience101(3), 485–512 (2000).
   PubMed Web of Science ®Google Scholar
• Rocca WA, Bower JH, Maraganore DM et al. Increased risk of parkinsonism in women who underwent oophorectomy before menopause. Neurology70(3), 200–209 (2008).
   PubMed Web of Science ®Google Scholar
• Farrag AK, Khedr EM, Abdel-Aleem H, Rageh TA. Effect of surgical menopause on cognitive functions. Dement. Geriatr. Cogn. Disord.13(3), 193–198 (2002).
   PubMed Web of Science ®Google Scholar
• Brinton RD, Tran J, Proffitt P, Montoya M. 17 b-estradiol enhances the outgrowth and survival of neocortical neurons in culture. Neurochem. Res.22(11), 1339–1351 (1997).
   PubMed Web of Science ®Google Scholar
• Halbreich U, Lumley LA, Palter S, Manning C, Gengo F, Joe SH. Possible acceleration of age effects on cognition following menopause. J. Psychiatr. Res.29(3), 153–163 (1995).
   PubMed Web of Science ®Google Scholar
• MacLennan AH, Henderson VW, Paine BJ et al. Hormone therapy, timing of initiation, and cognition in women aged older than 60 years: the REMEMBER pilot study. Menopause13(1), 28–36 (2006).
   PubMed Web of Science ®Google Scholar
• Rocca WA, Grossardt BR, Geda YE et al. Long-term risk of depressive and anxiety symptoms after early bilateral oophorectomy. Menopause15(6), 1050–1059 (2008).
   PubMed Web of Science ®Google Scholar
• Sherwin BB. Affective changes with estrogen and androgen replacement therapy in surgically menopausal women. J. Affect. Disord.14(2), 177–187 (1988).
   PubMed Web of Science ®Google Scholar
• Taylor M. Psychological consequences of surgical menopause. J. Reprod. Med.46(3 Suppl.), 317–324 (2001).
   PubMed Web of Science ®Google Scholar
• Kotz K, Alexander JL, Dennerstein L. Estrogen and androgen hormone therapy and well-being in surgically postmenopausal women. J. Womens Health (Larchmt)15(8), 898–908 (2006).
   PubMed Web of Science ®Google Scholar
• Bosworth HB, Bastian LA, Kuchibhatla MN et al. Depressive symptoms, menopausal status, and climacteric symptoms in women at midlife. Psychosom. Med.63(4), 603–608 (2001).
   PubMed Web of Science ®Google Scholar
• Shoupe D, Montz FJ, Lobo RA. The effects of estrogen and progestin on endogenous opioid activity in oophorectomized women. J. Clin. Endocrinol. Metab.60(1), 178–183 (1985).
   PubMed Web of Science ®Google Scholar
• Graziottin A, Koochaki PE, Rodenberg CA, Dennerstein L. The Prevalence of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women: an Epidemiological Study of Women in Four European Countries. J. Sex. Med.6(8), 2143–2153 (2009).
   PubMed Web of Science ®Google Scholar
• Sherwin BB, Gelfand MM. The role of androgen in the maintenance of sexual functioning in oophorectomized women. Psychosom. Med.49(4), 397–409 (1987).
   PubMed Web of Science ®Google Scholar
• Sands R, Studd J. Exogenous androgens in postmenopausal women. Am. J. Med.98(1A), 76S–79S (1995).
   PubMed Web of Science ®Google Scholar
• North American Menopause Society. The role of testosterone therapy in postmenopausal women: position statement of The North American Menopause Society. Menopause12(5), 496–511; quiz 649 (2005).
   PubMed Web of Science ®Google Scholar
• Nathors t-Boos J, von Schoultz B, Carlstrom K. Elective ovarian removal and estrogen replacement therapy – effects on sexual life, psychological well-being and androgen status. J. Psychosom. Obstet. Gynaecol.14(4), 283–293 (1993).
   PubMed Web of Science ®Google Scholar
• Shifren JL. Androgen deficiency in the oophorectomized woman. Fertil. Steril.77(Suppl. 4), S60–S62 (2002).
   PubMed Web of Science ®Google Scholar
• Holinka CF, Hata H, Kuramoto H, Gurpide E. Responses to estradiol in a human endometrial adenocarcinoma cell line (Ishikawa). J. Steroid Biochem.24(1), 85–89 (1986).
   PubMedGoogle Scholar
• Farnell YZ, Ing NH. The effects of estradiol and selective estrogen receptor modulators on gene expression and messenger RNA stability in immortalized sheep endometrial stromal cells and human endometrial adenocarcinoma cells. J. Steroid Biochem. Mol. Biol.84(4), 453–461 (2003).
   PubMed Web of Science ®Google Scholar
• Barakat RR, Bundy BN, Spirtos NM, Bell J, Mannel RS. Randomized double-blind trial of estrogen replacement therapy versus placebo in stage I or II endometrial cancer: a Gynecologic Oncology Group Study. J. Clin. Oncol.24(4), 587–592 (2006).
   PubMed Web of Science ®Google Scholar
• Creasman WT, Henderson D, Hinshaw W, Clarke-Pearson DL. Estrogen replacement therapy in the patient treated for endometrial cancer. Obstet. Gynecol.67(3), 326–330 (1986).
   PubMed Web of Science ®Google Scholar
• Chapman JA, DiSaia PJ, Osann K, Roth PD, Gillotte DL, Berman ML. Estrogen replacement in surgical stage I and II endometrial cancer survivors. Am. J. Obstet. Gynecol.175(5), 1195–1200 (1996).
   PubMed Web of Science ®Google Scholar
• Lee RB, Burke TW, Park RC. Estrogen replacement therapy following treatment for stage I endometrial carcinoma. Gynecol. Oncol.36(2), 189–191 (1990).
   PubMed Web of Science ®Google Scholar
• Suriano KA, McHale M, McLaren CE, Li KT, Re A, DiSaia PJ. Estrogen replacement therapy in endometrial cancer patients: a matched control study. Obstet. Gynecol.97(4), 555–560 (2001).
   PubMed Web of Science ®Google Scholar
• Shamshirsaz AA, Withiam-Leitch M, Odunsi K, Baker T, Frederick PJ, Lele S. Young patients with endometrial carcinoma selected for conservative treatment: a need for vigilance for synchronous ovarian carcinomas, case report and literature review. Gynecol. Oncol.104(3), 757–760 (2007).
   PubMed Web of Science ®Google Scholar
• Lee TS, Jung JY, Kim JW et al. Feasibility of ovarian preservation in patients with early stage endometrial carcinoma. Gynecol. Oncol.104(1), 52–57 (2007).
   PubMed Web of Science ®Google Scholar
• Walsh C, Holschneider C, Hoang Y, Tieu K, Karlan B, Cass I. Coexisting ovarian malignancy in young women with endometrial cancer. Obstet. Gynecol.106(4), 693–699 (2005).
   PubMed Web of Science ®Google Scholar
• Lee TS, Kim JW, Kim TJ et al. Ovarian preservation during the surgical treatment of early stage endometrial cancer: a nation-wide study conducted by the Korean Gynecologic Oncology Group. Gynecol. Oncol.115(1), 26–31 (2009).
   PubMed Web of Science ®Google Scholar
• Richter CE, Qian B, Martel M et al. Ovarian preservation and staging in reproductive-age endometrial cancer patients. Gynecol. Oncol.114(1), 99–104 (2009).
   PubMed Web of Science ®Google Scholar
• Wright JD, Buck AM, Shah M, Burke WM, Schiff PB, Herzog TJ. Safety of ovarian preservation in premenopausal women with endometrial cancer. J. Clin. Oncol.27(8), 1214–1219 (2009).
   PubMed Web of Science ®Google Scholar